DURHAM, N.C. & SEATTLE-- November 13, 2023--Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection. The...
Mike Grey will be speaking on a panel, Driving Life Sciences Discovery in 2011 and Beyond: Acquire or Partner? at BIOCOMS May breakfast meeting, San Diego CA.
News | 05. 04. 2011
